» Authors » Garima Jain

Garima Jain

Explore the profile of Garima Jain including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 43
Citations 163
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Connor D, Xie S, Jang J, Frazier A, Kedron P, Jain G, et al.
PNAS Nexus . 2025 Feb; 4(2):pgae587. PMID: 39906309
Urbanization has long fueled a dual narrative: cities are heralded as sources of economic dynamism and wealth creation yet criticized for fostering inequality and a range of social challenges. This...
2.
Kural S, Pathak A, Singh S, Jain G, Yadav M, Agarwal S, et al.
Ann Surg Oncol . 2024 Nov; 32(1):609-618. PMID: 39495364
Background: Bladder cancer (BCa) diagnosis relies on distinguishing muscle-invasive bladder cancer (MIBC) from non-muscle-invasive bladder cancer (NMIBC) forms. Transurethral resection of the bladder tumor (TURBT) is a standard procedure for...
3.
Kumar A, Jain G, Dutta P, Singh P, Alam N, Narayan S, et al.
Environ Sci Pollut Res Int . 2024 Oct; PMID: 39388087
Arsenic (As) contamination of agricultural soil has become a major concern due to its adverse effects on plant growth and human health. Selenium nanoparticles (SeNPs), a novel selenium (Se) source,...
4.
Pradhan V, Patra A, Jain A, Jain G, Kumar A, Dhar J, et al.
PLoS One . 2024 Sep; 19(9):e0304055. PMID: 39231125
Software reliability growth models (SRGMs) are universally admitted and employed for reliability assessment. The process of software reliability analysis is separated into two components. The first component is model construction,...
5.
Pathak A, Kural S, Singh S, Kumar L, Yadav M, Gupta M, et al.
Sci Rep . 2024 Aug; 14(1):18774. PMID: 39138232
The emergent role of nucleic acid-based biomarkers-microRNAs(miRNAs), long non-coding RNAs(lncRNAs), and messenger RNAs(mRNAs), is becoming increasingly prominent in disease diagnostics and risk assessment. qRT-PCR is the primary analytical method for...
6.
Jain G, Prajapati R, Bisen V
Cureus . 2024 Apr; 16(3):e56313. PMID: 38629024
Background: The coronavirus disease (COVID-19) pandemic has significantly impacted healthcare services globally, with particular challenges observed in maternal and child health (MCH) care. This study aimed to assess the impact...
7.
Kural S, Jain G, Agarwal S, Das P, Kumar L
Urol Oncol . 2024 Apr; 42(7):179-190. PMID: 38594151
Bladder cancer (BCa) stands as prevalent malignancy of the urinary system globally, especially among men. The clinical classification of BCa into non-muscle invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer...
8.
Dubey H, Jain G, Kumar C, Ranjan A, Batra A, Chellapuram S, et al.
Heliyon . 2023 Jun; 9(6):e16703. PMID: 37303538
Informed Consent: This is certified that the informed consent has been obtained from the patient.
9.
Jain G, Das P, Ranjan P, Neha , Valderrama F, Cieza-Borrella C
Front Genet . 2023 Feb; 14:1065757. PMID: 36741322
Prostate cancer is the second most common male cancer worldwide showing the highest rates of incidence in Western Europe. Although the measurement of serum prostate-specific antigen levels is the current...
10.
Gajendra S, Gupta R, Thakral D, Gupta S, Jain G, Bakhshi S, et al.
Int J Lab Hematol . 2022 Dec; 45(2):221-228. PMID: 36504282
Introduction: CD34 and HLA-DR negativity is often used as a characteristic immunophenotypic feature of acute promyelocytic leukaemia (APL) that differentiates APL from other subtypes of acute myeloid leukaemia (AML). However,...